EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Auregen BioTherapeutics was filed as Word mark on 02/22/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/04/2018.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 016391047 |
| Application date | February 22, 2017 |
| Publication date | March 23, 2017 |
| Entry date | April 4, 2018 |
| Expiration date | February 22, 2027 |
Trademark owner
Avenue Giuseppe-Motta 31-37
1202 Genève
CH
1202 Genève
CH
Trademark representatives
22 Chemin des Esserts
74200 Thonon les Bains
FR
Objection / Complaint
06/26/2017: Likelihood of confusion
Applicant
bioMérieux
goods and services
1
Stem cells for research purposes; Stem cells for scientific purposes; Stem cells for research or scientific purposes; Stem cells, other than for medical or veterinary purposes; Hydrogel polymer coatings; Lactic acid polymers; Aqueous linear polymer gels; Photo curable compositions comprising polymers; Chemicals for use in polymerisations; Synthesised biological tissues and tissue matrices, namely human and animal organ, connective, epithelial, muscular and nervous tissues and tissue matrices, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
5
Pharmaceutical preparations; Cellulose nanofibril-based preparations for use in 3D bio-printing of tissues and organs; Pharmaceutical preparations of regenerative tissue; Biological implants; Biological tissue for implantation; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants for guided tissue regeneration; Implants comprising living tissue; Implantable materials for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants grown from stem cells [living tissues]; Transdermal patches; Transplants [living tissues]; Antibodies; Stem cells for medical purposes; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules for supporting tissue development; Hemostatic gel matrix preparations for treating wounds; Natural biomaterials for bone, blood and tissue augmentation, for medical purposes; Processed human donor skin for the replacement of soft tissue; Pharmaceuticals for tissue regeneration, tissue repair and tissue treatment, whether human or animal tissue; Pharmaceuticals for the treatment of bone diseases, cartilage diseases, vascular diseases, neuronal degeneration, degeneration of tendons and ligaments, retinal degeneration, renal degeneration, soft tissue degeneration, abnormal cell proliferation diseases; Bone filler biomaterials; Cartilage filler biomaterials; Surgical implants (living tissues); Surgical tissues; Surgical implants grown from stem cells; Biological tissue cultures for medical purposes; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
7
3D printers; Three-dimensional (3D) bio-printers; Computer-driven machines and components therefor, for the production of three-dimensional parts; Machines for the production of three-dimensional models, namely, Computer-aided modelling apparatus; Machines for manufacturing three dimensional (3D) living tissues; Machines, namely three-dimensional (3D) bio-printers, for the printing of living tissues; Cartridges for containing printing material, Cartridges containing biological printing materials, printing cartridges containing biomaterials for three-dimensional printing
9
Laboratory apparatus for the production of three-dimensional living tissues and organs; Biochips for the production of three-dimensional living tissues and organs; Bioreactor for cell culturing; Bioreactors for laboratory use; Bioreactors for research use; Cell culture apparatus for laboratory use; Print heads for inkjet printers; scientific research and laboratory apparatus and instruments in the field of cytology; laboratory apparatus and instruments for use in biopharmaceutical discovery and development; Parts and fittings for any of the aforementioned goods; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
10
Orthopedic articles; Artificial limbs; Artificial implants; Bone substitutes for surgical use; Synthetic biomaterials for tissue substitution, for restoring, maintaining and/or repairing the function of diseased or damaged human or animal tissue (tissue engineering); Synthetic implants and transplants and modified implants and transplants, tissues, cells and/or molecules for replacing and/or supporting the function of missing or injured body parts; Synthetic hard and soft tissues, in particular synthetic bone for transplantation, synthetic biomaterials for the replacement of bone, vessels, tissue and adipose tissue; Modified implants and transplants of endogenous material, tissues, cells and/or molecules, for replacing and/or supporting the function of missing or injured body parts; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
40
3D printing services; Rental of 3D printers; Custom creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing; Biological printing
42
Technical research in the fields of biomimetics, biomaterials, material adaptation, 3D bioprinting and tissue engineering; Research and development of medical devices; Research in the field of nanotechnology and nanomaterials; Research relating to synthetic biology; Research relating to robotics; Research relating to biological engineering; Research relating to nanotherapy; Research relating to three-dimensional biological printing; Research relating to tissue engineering; scientific and medical research and development in the field of bioprinting; Research and development of 3D technology and processes; Development of rapid prototyping equipment; Technical consultancy relating to rapid prototyping; Scientific research consultancy in the fields of three-dimensional printing; Scientific services relating to the isolation and culture of human tissues and cells; Scientific and medical research and development in the field of tissue fabrication; Development and culture of artificial tissues and cells (tissue engineering); Tissue engineering; Industrial analysis and research services in the field of tissue engineering, research in the field of regenerative biotherapies, genomics, biotechnology, chemical preparations and pharmaceuticals; Research and testing in the field of regenerative biotherapies, genomics, biotechnology, chemical preparations and pharmaceuticals; Research and development of new products in the field of regenerative biotherapies, genomics, biotechnology, chemical preparations and pharmaceuticals; Design and development of computer hardware and software; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
44
Medical services, namely in the field of gene and cellular immunotherapies and transplantation, monitoring and reporting services; Arranging of medical treatment; Consultancy in the fields of medical treatments and medicines, human cell and tissue banking services; Medical services relating to the taking and preservation of human blood and cells for medical purposes; The aforesaid goods being for in vivo use in the fields of therapeutic and/or cosmetic treatments
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 25, 2017 | Change Representative, Registered |
ID: 11016391047